Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Robotic Gait Rehabilitation in Parkinson's Disease

NCT: NCT05218187 · TERMINATED

NCT IDNCT05218187
StatusTERMINATED
Start Date2022-01-10
Completion2025-08-22

Brief Summary

The purpose of this study is to investigate the implementation of a novel gait rehabilitation stimulus (G-EO System) that could advance current clinical practices. The goal is to establish the safety and feasibility of gait training using the G-EO System as well as investigating the impact on mobility, function, quality of life, and participatory outcomes. Research Design: We propose a single-blinded, randomized trial of electromechanically-assisted gait training using the G-EO System in patients with Parkinson's disease with gait disability. Specific Aim 1 will establish the safety and feasibility of gait training using the G-EO System. Specific Aim 2 will determine the efficacy of gait training using the G-EO System for improving mobility, function, and quality of life

Frequently Asked Questions

What is Robotic Gait Rehabilitation in Parkinson's Disease?

Robotic Gait Rehabilitation in Parkinson's Disease is a clinical trial registered under NCT05218187. Current status: TERMINATED.

What is the status of NCT05218187?

The current status of NCT05218187 (Robotic Gait Rehabilitation in Parkinson's Disease) is: TERMINATED.

When did Robotic Gait Rehabilitation in Parkinson's Disease start?

Robotic Gait Rehabilitation in Parkinson's Disease started on 2022-01-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.